Meeting
2020 ASCO Virtual Scientific Program
Evaluation of spatiotemporal heterogeneity of tumor mutational burden (TMB) in gastroesophageal adenocarcinoma (GEA) at baseline diagnosis and after chemotherapy.
Authors
Katherine I. Zhou
University of Chicago, Chicago, IL
Katherine I. Zhou , Bryan Peterson , Anthony Serritella , Natalie Reizine , Yan Wang , Daniel V.T. Catenacci
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Citation
J Clin Oncol 38: 2020 (suppl; abstr 4546)
DOI
10.1200/JCO.2020.38.15_suppl.4546
Abstract #
4546
Poster Bd #
154
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Microsatellite instability (MSI), mismatch repair (MMR), and tumor mutational burden (TMB) as predictive biomarkers for immune checkpoint inhibitor (ICI) effectiveness in real-world patients with metastatic colorectal cancer (mCRC).
First Author: Haley Ellis
Poster
2023 ASCO Annual Meeting
Tumor mutational burden as a predictive biomarker for molecularly matched therapy in two independent pan-cancer cohorts.
First Author: Damian Tobias Rieke
Poster
2023 ASCO Annual Meeting
Evaluation of microsatellite instability status, a definitive predictive biomarker for immune checkpoint inhibitors (ICI), in underrepresented minorities (URM) with gastrointestinal (GI) cancers.
First Author: Fiyinfolu Balogun
Poster
2023 ASCO Annual Meeting
STK11 alterations as predictive biomarkers of resistance to immune checkpoint inhibitors in multiple cancers with mismatch repair gene alterations.
First Author: Michael Iglesia